2010
Time to Depression Treatment in Primary Care Among HIV-infected and Uninfected Veterans
Hooshyar D, Goulet J, Chwastiak L, Crystal S, Gibert C, Mattocks K, Rimland D, Rodriguez-Barradas M, Justice AC, for the VACS Project Team. Time to Depression Treatment in Primary Care Among HIV-infected and Uninfected Veterans. Journal Of General Internal Medicine 2010, 25: 656-662. PMID: 20405335, PMCID: PMC2881956, DOI: 10.1007/s11606-010-1323-z.Peer-Reviewed Original ResearchConceptsPHQ-9 assessmentMental health visitsDepressed HIVUninfected patientsHIV serostatusDepression treatmentPrimary careDepression severityHealth visitsInclusion criteriaPatient Health Questionnaire scoresUntreated depressive symptomsPrimary care treatmentKaplan-Meier curvesPHQ-9 scoresGeneral medicine clinicProportional hazards methodsStudy inclusion criteriaMajority of depressionsAntidepressant receiptBackgroundMultiple factorsUninfected veteransPatient characteristicsProspective cohortTotal cohort
1998
Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy
Weiss M, Rodby R, Justice A, Hricik D, Group T. Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Kidney International 1998, 54: 193-202. PMID: 9648079, DOI: 10.1046/j.1523-1755.1998.00982.x.Peer-Reviewed Original ResearchConceptsC-reactive proteinProtein-bound pentosidineDiabetic nephropathyInterleukin-6Serum creatinineFree pentosidineMonocyte/macrophage activationAdvanced glycation end product pentosidineBaseline disease activityDegree of proteinuriaSubgroup of patientsImmune activation responseProportional hazards methodsDisease activityInflammatory markersCreatinine levelsRenal functionDiabetes mellitusSerum levelsDiabetic complicationsProgression rateGroup trialsHazards methodsMacrophage activationNephropathy